Skip to main content
ARS Home » Southeast Area » Little Rock, Arkansas » Arkansas Children's Nutrition Center » Research » Publications at this Location » Publication #216571

Title: Kruppel-like Factor 9 is a Negative Regulator of Ligand-dependent Estrogen Receptor Alpha Signaling in Ishikawa Endometrial Adenocarcinoma Cells

Author
item VELARDE, MICHAEL
item ZENG, ZHAOYANG
item MCQUOWN, JANELLE
item SIMMEN, FRANK
item SIMMEN, ROSALIA

Submitted to: Molecular Endocrinology
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 8/9/2007
Publication Date: 12/1/2007
Citation: Velarde, M.C., Zeng, Z., Mcquown, J., Simmen, F.A., Simmen, R.C. 2007. Kruppel-like Factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells. Molecular Endocrinology. 21(12):2988-3001.

Interpretive Summary: Excess estrogen is a major underlying cause of uterine cancer in women. Thus, information on ways to control the excessive actions of estrogen by regulating the amounts of protein that bind it to effect biological action in the uterus is of major importance. Our study suggests that the presence of another protein, termed Kruppel-like Factor 9, in the uterus can inhibit the actions of estrogen. We suggest that uterine cancer may be caused by loss of this protein, and that treatment of uterine cancer may require increasing the presence or amounts of this protein.

Technical Abstract: Estrogen (E) and progesterone (P), acting through their respective receptors and other nuclear proteins, exhibit opposing activities in target cells. We previously reported that Krüppel-like factor 9 (KLF9) cooperates with progesterone receptor (PR) to facilitate P-dependent gene transcription in uterine epithelial cells. Here we evaluated whether KLF9 may further support PR function by directly opposing estrogen receptor (ER) signaling. Using human Ishikawa endometrial epithelial cells, we showed that 17'-estradiol (E2)-dependent down-regulation of ER' expression was reversed by a small interfering RNA (siRNA) to KLF9. Transcription assays with the E2-sensitive 4xERE-TK-promoter-luciferase reporter gene demonstrated inhibition of ligand-dependent ER' transactivation with ectopic KLF9 expression. E2 induced PR-A/B and PR-B isoform expression in the absence of effects on KLF9 levels. Addition of KLF9 siRNA augmented E2-induction of PR-A/B while abrogating that of PR-B, indicating selective E2-mediated inhibition of PR-A by KLF9. Chromatin immunoprecipitation of the ER' minimal promoter demonstrated KLF9 promotion of E2-dependent ER' association to a region containing functional GC-rich motifs. KLF9 inhibited the recruitment of the ER' co-activator Sp1 to the PR proximal promoter region containing a half-ERE and GC-rich sites, but had no effect on Sp1 association to the PR distal promoter region containing GC-rich sequences. In vivo association of KLF9 and Sp1, but not of ER' with KLF9 or Sp1, was observed in control and E2-treated cells. Our data identify KLF9 as a transcriptional repressor of ER' signaling and suggest that it may function at the node of PR and ER genomic pathways to influence cell proliferation.